Atrial Fibrillation: Technologies and Global Markets
Report Scope:
The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.
Devices included as a part of market estimates are:Catheter ablation products, including electrophysiology ablation catheters, electrophysiology diagnostic catheters, lab systems (3D electro-anatomical mapping systems, robotic catheter navigation systems, intracardiac echocardiography systems, recording systems, ablation generators and irrigation pumps), access devices and consumables. Left atrial appendage closure devices, including all occlusion device systems and implantable devices employed in endocardial and epicardial LAA procedures, which include cardiac plugs, clips and suture delivery systems.
Devices excluded from market estimates are: Pharmacological drugs employed in standalone and combination of ablation procedures. Devices like defibrillators and preliminary diagnostic devices, including cardiac monitors and Holter monitors (including implantable Holter monitors). ECG machines and consumables, wearable devices, implantable loop recorders (ILR), pacemakers, and electrical cardioversion devices. Further surgical ablation products employed in Cox-Maze IV or Mini-Maze surgery and thoracoscopy visualization devices. Imaging systems such as Rotational angiography, fluoroscopy X-ray systems, CT and MRI imaging systems.
The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.
The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.
Report Includes::
The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.
Devices included as a part of market estimates are:
Devices excluded from market estimates are:
The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.
The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.
Report Includes::
- 25 data tables and 13 additional tables
- An overview of the global market for atrial fibrillation and technologies
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Detailed description of the market for drug treatment, surgical intervention, and other aspects of atrial fibrillation
- Discussion of the types of atrial fibrillation treatment
- A look into various government regulations
- Insight into the emerging developmental technologies and clinical trials for new technology for atrial fibrillation
- Company profiles of the manufacturers of surgical equipment, surgical accessories, and pharmaceuticals, including Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic and Philips Healthcare
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 BACKGROUND
Heart Structure and Function
Cardiac Arrhythmia
Treadmill Run Test Stress Test
Holter Monitoring
Echocardiography
Electrophysiologic Testing
Atrial Fibrillation (AFib)
Symptoms
Global Epidemiology
Economic Burden of Atrial Fibrillation
Risk Factors
Complications of Atrial Fibrillation
Patterns of Atrial Fibrillation
Current Standard of Care for Atrial Fibrillation
Diagnosis
Treatment of AFib
CHAPTER 4 MARKET OVERVIEW
Market Dynamics
Market Drivers
Market Restraints
Emerging Trends
Regulatory Landscape
Regulation in Europe
Regulation in the U.S.
Regulation in Japan
Regulation in China
Regulation in India
CHAPTER 5 MARKET BREAKDOWN BY DEVICE TYPE
Introduction and Global Markets
Catheter Ablation Devices
Overview
Market Size and Forecast
Catheter Ablation Devices by Type
Left Atrial Appendage (LAA) Closure Devices
Overview
Cost Benefits of Left Atrial Appendage Closure Devices vs. Pharmacological Therapy
Market Size and Forecast
Types of Left Atrial Appendage Implantation
CHAPTER 6 MARKET BREAKDOWN BY REGION
Introduction
North America
U.S.
Canada
Europe
Germany
France
Asia-Pacific
China
Japan
India
Rest of the World
CHAPTER 7 COMPETITIVE LANDSCAPE AND RECENT DevelopmentS
Market Share Analysis
Atrial Fibrillation: Company Market Share Analysis
Strategies Adopted by Market Leaders
Catheter Ablation Devices: Company Market Share Analysis
Left Atrial Appendage Closure Devices: Company Market Share Analysis
Barriers to the Entry for New Players
High Degree of Competitiveness
Product Portfolio Analysis
Catheter Ablation Devices Product Portfolio Analysis
Left Atrial Appendage Closure Devices Product Portfolio Analysis
Key Recent Industry Events
CHAPTER 8 COMPANY PROFILES
ABBOTT LABORATORIES
Company Overview
Financials
Atrial Fibrillation Business
Product Portfolio
Development and Strategies
ABLACOR MEDICAL CORP.
Company Overview
ACUTUS MEDICAL INC
Company Overview
AEGIS MEDICAL INNOVATIONS
Company Overview
AFREEZE GMBH
Company Overview
AURIS HEALTH (HANSEN MEDICAL)
Company Overview
ATRICURE INC
Company Overview
Financials
Business of Atrial Fibrillation
Product Portfolio
BIOTRONIK
Company Overview
BOSTON SCIENTIFIC
Company Overview
Financials
Product Portfolio
CARDIOFOCUS
Company Overview
CATHRX
Company Overview
GE HEALTHCARE
Company Overview
Financials
JOHNSON & JOHNSON
Company Overview
Financials
Business of Atrial Fibrillation
Product Portfolio
KARDIUM
Company Overview
LIFETECH SCIENTIFIC CORP.
Company Overview
LUXCATH
Company Overview
MEDTRONIC
Company Overview
Financials
Product Portfolio
MICROPORT SCIENTIFIC CORP.
Company Overview
Financials
PHILIPS HEALTHCARE
Company Overview
Financials
SENTREHEART
Company Overview
STEREOTAXIS
Company Overview
CHAPTER 9 APPENDIX: ACRONYMS
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 BACKGROUND
Heart Structure and Function
Cardiac Arrhythmia
Treadmill Run Test Stress Test
Holter Monitoring
Echocardiography
Electrophysiologic Testing
Atrial Fibrillation (AFib)
Symptoms
Global Epidemiology
Economic Burden of Atrial Fibrillation
Risk Factors
Complications of Atrial Fibrillation
Patterns of Atrial Fibrillation
Current Standard of Care for Atrial Fibrillation
Diagnosis
Treatment of AFib
CHAPTER 4 MARKET OVERVIEW
Market Dynamics
Market Drivers
Market Restraints
Emerging Trends
Regulatory Landscape
Regulation in Europe
Regulation in the U.S.
Regulation in Japan
Regulation in China
Regulation in India
CHAPTER 5 MARKET BREAKDOWN BY DEVICE TYPE
Introduction and Global Markets
Catheter Ablation Devices
Overview
Market Size and Forecast
Catheter Ablation Devices by Type
Left Atrial Appendage (LAA) Closure Devices
Overview
Cost Benefits of Left Atrial Appendage Closure Devices vs. Pharmacological Therapy
Market Size and Forecast
Types of Left Atrial Appendage Implantation
CHAPTER 6 MARKET BREAKDOWN BY REGION
Introduction
North America
U.S.
Canada
Europe
Germany
France
Asia-Pacific
China
Japan
India
Rest of the World
CHAPTER 7 COMPETITIVE LANDSCAPE AND RECENT DevelopmentS
Market Share Analysis
Atrial Fibrillation: Company Market Share Analysis
Strategies Adopted by Market Leaders
Catheter Ablation Devices: Company Market Share Analysis
Left Atrial Appendage Closure Devices: Company Market Share Analysis
Barriers to the Entry for New Players
High Degree of Competitiveness
Product Portfolio Analysis
Catheter Ablation Devices Product Portfolio Analysis
Left Atrial Appendage Closure Devices Product Portfolio Analysis
Key Recent Industry Events
CHAPTER 8 COMPANY PROFILES
ABBOTT LABORATORIES
Company Overview
Financials
Atrial Fibrillation Business
Product Portfolio
Development and Strategies
ABLACOR MEDICAL CORP.
Company Overview
ACUTUS MEDICAL INC
Company Overview
AEGIS MEDICAL INNOVATIONS
Company Overview
AFREEZE GMBH
Company Overview
AURIS HEALTH (HANSEN MEDICAL)
Company Overview
ATRICURE INC
Company Overview
Financials
Business of Atrial Fibrillation
Product Portfolio
BIOTRONIK
Company Overview
BOSTON SCIENTIFIC
Company Overview
Financials
Product Portfolio
CARDIOFOCUS
Company Overview
CATHRX
Company Overview
GE HEALTHCARE
Company Overview
Financials
JOHNSON & JOHNSON
Company Overview
Financials
Business of Atrial Fibrillation
Product Portfolio
KARDIUM
Company Overview
LIFETECH SCIENTIFIC CORP.
Company Overview
LUXCATH
Company Overview
MEDTRONIC
Company Overview
Financials
Product Portfolio
MICROPORT SCIENTIFIC CORP.
Company Overview
Financials
PHILIPS HEALTHCARE
Company Overview
Financials
SENTREHEART
Company Overview
STEREOTAXIS
Company Overview
CHAPTER 9 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table: Global Market for Atrial Fibrillation Devices, by Type, Through 2023
Table 1: Breakdown of U.S. Cost Burden of Cardiovascular Disease, 2015 and 2035
Table 2: Breakdown of U.S. Cost Burden of Cardiovascular Diseases, by Type 2015 and 2035
Table 3: Complications of Catheter Ablations and Incidence Rates, 2016
Table 4: Cardiology Workforce Demand and Supply Trends, by Cardiac Subspecialty, 2009
Table 5: Catheter Ablation and Left Atrial Appendage Closure Device Approvals, 2015-2018
Table 6: Global Market for Atrial Fibrillation Devices, by Major Segment, Through 2023
Table 7: Global Market for Catheter Ablation Devices, by Region, Through 2023
Table 8: Global Market for Catheter Ablation Devices, by Type, Through 2023
Table 9: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
Table 10: Global Market for Electrophysiology Diagnostic Catheters, by Region, Through 2023
Table 11: Global Market for Lab Systems, by Region, Through 2023
Table 12: Global Market for Access Devices, by Region, Through 2023
Table 13: Cost Benefit Analysis of Left Atrial Appendage Closure vs. Anticoagulant Drugs
Table 14: Global Market for Left Atrial Appendage Closure Devices, by Region, Through 2023
Table 15: Global Market for Left Atrial Appendage Closure Devices, by Type, Through 2023
Table 16: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, Through 2023
Table 17: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, Through 2023
Table 18: Global Market for Atrial Fibrillation Devices, by Region, Through 2023
Table 19: North American Market for Atrial Fibrillation Devices, by Country, Through 2023
Table 20: European Market for Atrial Fibrillation Devices, by Country, Through 2023
Table 21: Asia-Pacific Market for Atrial Fibrillation Devices, by Country, Through 2023
Table 22: Product Portfolio Analysis
Table 23: Catheter Ablation Devices Market: Company Portfolio Comparison
Table 24: Left Atrial Appendage Closure Devices Market: Company Portfolio Comparison
Table 25: Key Industry Events in the Atrial Fibrillation Device Market, January 2015-July 2018
Table 26: Abbott Laboratories: Net Revenue, 2015-2017
Table 27: Abbott Laboratories: Products
Table 28: AtriCure: Net Revenue, 2015-2017
Table 29: AtriCure: Products
Table 30: Boston Scientific: Net Revenue, 2015-2017
Table 31: Boston Scientific: Products
Table 32: Johnson & Johnson: Net Revenue, 2015-2017
Table 33: Johnson & Johnson (Biosense Webster): Products and Services
Table 34: Medtronic: Net Revenue, 2015-2017
Table 35: Medtronic: Products
Table 36: MicroPort: Net Revenue, 2015-2017
Table 37: Sterotaxis: Net Revenue, 2015-2017
Table 38: Acronyms Used in Atrial Fibrillation
Summary Table: Global Market for Atrial Fibrillation Devices, by Type, Through 2023
Table 1: Breakdown of U.S. Cost Burden of Cardiovascular Disease, 2015 and 2035
Table 2: Breakdown of U.S. Cost Burden of Cardiovascular Diseases, by Type 2015 and 2035
Table 3: Complications of Catheter Ablations and Incidence Rates, 2016
Table 4: Cardiology Workforce Demand and Supply Trends, by Cardiac Subspecialty, 2009
Table 5: Catheter Ablation and Left Atrial Appendage Closure Device Approvals, 2015-2018
Table 6: Global Market for Atrial Fibrillation Devices, by Major Segment, Through 2023
Table 7: Global Market for Catheter Ablation Devices, by Region, Through 2023
Table 8: Global Market for Catheter Ablation Devices, by Type, Through 2023
Table 9: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
Table 10: Global Market for Electrophysiology Diagnostic Catheters, by Region, Through 2023
Table 11: Global Market for Lab Systems, by Region, Through 2023
Table 12: Global Market for Access Devices, by Region, Through 2023
Table 13: Cost Benefit Analysis of Left Atrial Appendage Closure vs. Anticoagulant Drugs
Table 14: Global Market for Left Atrial Appendage Closure Devices, by Region, Through 2023
Table 15: Global Market for Left Atrial Appendage Closure Devices, by Type, Through 2023
Table 16: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, Through 2023
Table 17: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, Through 2023
Table 18: Global Market for Atrial Fibrillation Devices, by Region, Through 2023
Table 19: North American Market for Atrial Fibrillation Devices, by Country, Through 2023
Table 20: European Market for Atrial Fibrillation Devices, by Country, Through 2023
Table 21: Asia-Pacific Market for Atrial Fibrillation Devices, by Country, Through 2023
Table 22: Product Portfolio Analysis
Table 23: Catheter Ablation Devices Market: Company Portfolio Comparison
Table 24: Left Atrial Appendage Closure Devices Market: Company Portfolio Comparison
Table 25: Key Industry Events in the Atrial Fibrillation Device Market, January 2015-July 2018
Table 26: Abbott Laboratories: Net Revenue, 2015-2017
Table 27: Abbott Laboratories: Products
Table 28: AtriCure: Net Revenue, 2015-2017
Table 29: AtriCure: Products
Table 30: Boston Scientific: Net Revenue, 2015-2017
Table 31: Boston Scientific: Products
Table 32: Johnson & Johnson: Net Revenue, 2015-2017
Table 33: Johnson & Johnson (Biosense Webster): Products and Services
Table 34: Medtronic: Net Revenue, 2015-2017
Table 35: Medtronic: Products
Table 36: MicroPort: Net Revenue, 2015-2017
Table 37: Sterotaxis: Net Revenue, 2015-2017
Table 38: Acronyms Used in Atrial Fibrillation
LIST OF FIGURES
Summary Figure: Global Market for Atrial Fibrillation Devices, by Type, 2016-2023
Figure 1: Prevalence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
Figure 2: Incidence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
Figure 3: Trends in Inpatient Stays of Atrial Fibrillation Affected Patients, by Age Group, 2014
Figure 4: Atrial Fibrillation Market Dynamics
Figure 5: Trends in World Aging Population, 2017 and 2050
Figure 6: AFib Population Trends for the U.S. and Europe, 2010 and 2050
Figure 7: Global Market for Atrial Fibrillation Devices, by Major Segment, 2016-2023
Figure 8: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2017
Figure 9: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2023
Figure 10: Global Market for Catheter Ablation Devices, 2016-2023
Figure 11: Global Market for Catheter Ablation Devices, by Region, 2016-2023
Figure 12: Global Market Share for Catheter Ablation Devices, by Region, 2017
Figure 13: Global Market Share for Catheter Ablation Devices, by Region, 2023
Figure 14: Global Market for Catheter Ablation Devices, by Type, 2016-2023
Figure 15: Global Market Share for Catheter Ablation Devices, by Type, 2017
Figure 16: Global Market Share for Catheter Ablation Devices, by Type, 2023
Figure 17: Global Market for Electrophysiology Ablation Catheters, 2016-2023
Figure 18: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
Figure 19: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2017
Figure 20: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2023
Figure 21: Global Market for Electrophysiology Diagnostic Catheters, 2016-2023
Figure 22: Global Market for Electrophysiology Diagnostic Catheters, by Region, 2016-2023
Figure 23: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2017
Figure 24: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2023
Figure 25: Global Market for Lab Systems, 2016-2023
Figure 26: Global Market for Lab Systems, by Region, 2016-2023
Figure 27: Global Market Share for Lab Systems, by Region, 2017
Figure 28: Global Market Share for Lab Systems, by Region, 2023
Figure 29: Global Market for Access Devices, 2016-2023
Figure 30: Global Market for Access Devices, by Region, 2016-2023
Figure 31: Global Market for Left Atrial Appendage Closure Devices, 2016-2023
Figure 32: Global Market for Left Atrial Appendage Closure Devices, by Region, 2016-2023
Figure 33: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2017
Figure 34: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2023
Figure 35: Global Market for Left Atrial Appendage Closure Devices, by Type, 2016-2023
Figure 36: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2017
Figure 37: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2023
Figure 38: Global Market for Endocardial Left Atrial Appendage Closure Devices, 2016-2023
Figure 39: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
Figure 40: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2017
Figure 41: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2023
Figure 42: Global Market for Epicardial Left Atrial Appendage Closure Devices, 2016-2023
Figure 43: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
Figure 44: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2017
Figure 45: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2023
Figure 46: North American Market for Atrial Fibrillation Devices, 2016-2023
Figure 47: European Market for Atrial Fibrillation Devices, 2016-2023
Figure 48: Asia-Pacific Market for Atrial Fibrillation Devices, 2016-2023
Figure 49: RoW Market for Atrial Fibrillation Devices, 2016-2023
Figure 50: Global Market Share for Atrial Fibrillation Devices, by Company, 2017
Figure 51: Global Market Share for Catheter Ablation Devices, by Company, 2017
Figure 52: Global Market Share for Atrial Appendage Closure Devices, by Company, 2017
Figure 53: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
Figure 54: Abbott Laboratories: Revenue, by Country, 2015-2017
Figure 55: Abbott Laboratories: Revenue Share, by Cardiology Segment, 2015-2017
Figure 56: AtriCure: Revenue, by Product Segment, 2015-2017
Figure 57: AtriCure: Revenue Share, by Region/Country, 2017
Figure 58: Boston Scientific: Revenue, by Business Segment, 2015-2017
Figure 59: Boston Scientific: Revenue Share, by Business Segment, 2017
Figure 60: GE Healthcare: Annual Revenue, 2015-2017
Figure 61: GE Healthcare: Revenue Share, by Region, 2017
Figure 62: GE Healthcare: Revenue Share, by Product Division, 2017
Figure 63: Johnson & Johnson: Revenue Share, by Business Segment, 2017
Figure 64: Johnson & Johnson: Revenue Share, by Medical Device Segment, 2017
Figure 65: Medtronic: Revenue, by Business Segment, 2015-2017
Figure 66: Medtronic: Revenue Share, by Business Segment, 2017
Figure 67: Philips Sales Revenue, 2015-2017
Figure 68: Philips Sales Revenue Share, by Business Unit, 2016
Figure 69: Philips Sales Revenue Share, by Business Unit, 2017
Figure 70: Stereotaxis: Revenue, by Business Segment, 2015-2017
Summary Figure: Global Market for Atrial Fibrillation Devices, by Type, 2016-2023
Figure 1: Prevalence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
Figure 2: Incidence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
Figure 3: Trends in Inpatient Stays of Atrial Fibrillation Affected Patients, by Age Group, 2014
Figure 4: Atrial Fibrillation Market Dynamics
Figure 5: Trends in World Aging Population, 2017 and 2050
Figure 6: AFib Population Trends for the U.S. and Europe, 2010 and 2050
Figure 7: Global Market for Atrial Fibrillation Devices, by Major Segment, 2016-2023
Figure 8: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2017
Figure 9: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2023
Figure 10: Global Market for Catheter Ablation Devices, 2016-2023
Figure 11: Global Market for Catheter Ablation Devices, by Region, 2016-2023
Figure 12: Global Market Share for Catheter Ablation Devices, by Region, 2017
Figure 13: Global Market Share for Catheter Ablation Devices, by Region, 2023
Figure 14: Global Market for Catheter Ablation Devices, by Type, 2016-2023
Figure 15: Global Market Share for Catheter Ablation Devices, by Type, 2017
Figure 16: Global Market Share for Catheter Ablation Devices, by Type, 2023
Figure 17: Global Market for Electrophysiology Ablation Catheters, 2016-2023
Figure 18: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
Figure 19: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2017
Figure 20: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2023
Figure 21: Global Market for Electrophysiology Diagnostic Catheters, 2016-2023
Figure 22: Global Market for Electrophysiology Diagnostic Catheters, by Region, 2016-2023
Figure 23: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2017
Figure 24: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2023
Figure 25: Global Market for Lab Systems, 2016-2023
Figure 26: Global Market for Lab Systems, by Region, 2016-2023
Figure 27: Global Market Share for Lab Systems, by Region, 2017
Figure 28: Global Market Share for Lab Systems, by Region, 2023
Figure 29: Global Market for Access Devices, 2016-2023
Figure 30: Global Market for Access Devices, by Region, 2016-2023
Figure 31: Global Market for Left Atrial Appendage Closure Devices, 2016-2023
Figure 32: Global Market for Left Atrial Appendage Closure Devices, by Region, 2016-2023
Figure 33: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2017
Figure 34: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2023
Figure 35: Global Market for Left Atrial Appendage Closure Devices, by Type, 2016-2023
Figure 36: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2017
Figure 37: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2023
Figure 38: Global Market for Endocardial Left Atrial Appendage Closure Devices, 2016-2023
Figure 39: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
Figure 40: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2017
Figure 41: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2023
Figure 42: Global Market for Epicardial Left Atrial Appendage Closure Devices, 2016-2023
Figure 43: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
Figure 44: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2017
Figure 45: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2023
Figure 46: North American Market for Atrial Fibrillation Devices, 2016-2023
Figure 47: European Market for Atrial Fibrillation Devices, 2016-2023
Figure 48: Asia-Pacific Market for Atrial Fibrillation Devices, 2016-2023
Figure 49: RoW Market for Atrial Fibrillation Devices, 2016-2023
Figure 50: Global Market Share for Atrial Fibrillation Devices, by Company, 2017
Figure 51: Global Market Share for Catheter Ablation Devices, by Company, 2017
Figure 52: Global Market Share for Atrial Appendage Closure Devices, by Company, 2017
Figure 53: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
Figure 54: Abbott Laboratories: Revenue, by Country, 2015-2017
Figure 55: Abbott Laboratories: Revenue Share, by Cardiology Segment, 2015-2017
Figure 56: AtriCure: Revenue, by Product Segment, 2015-2017
Figure 57: AtriCure: Revenue Share, by Region/Country, 2017
Figure 58: Boston Scientific: Revenue, by Business Segment, 2015-2017
Figure 59: Boston Scientific: Revenue Share, by Business Segment, 2017
Figure 60: GE Healthcare: Annual Revenue, 2015-2017
Figure 61: GE Healthcare: Revenue Share, by Region, 2017
Figure 62: GE Healthcare: Revenue Share, by Product Division, 2017
Figure 63: Johnson & Johnson: Revenue Share, by Business Segment, 2017
Figure 64: Johnson & Johnson: Revenue Share, by Medical Device Segment, 2017
Figure 65: Medtronic: Revenue, by Business Segment, 2015-2017
Figure 66: Medtronic: Revenue Share, by Business Segment, 2017
Figure 67: Philips Sales Revenue, 2015-2017
Figure 68: Philips Sales Revenue Share, by Business Unit, 2016
Figure 69: Philips Sales Revenue Share, by Business Unit, 2017
Figure 70: Stereotaxis: Revenue, by Business Segment, 2015-2017